NASDAQ · Financial Statements
InMed Pharmaceuticals Inc. (INM) Revenue, Earnings & Financial Statements
$15.56
NASDAQ: INM
Market Cap $8.55M
Data as of Nov 9, 2026 close · Source: Financial Modeling Prep (methodology)
Full income statement, balance sheet, and cash flow statement for InMed Pharmaceuticals Inc. (INM), plus valuation and return ratios.
Annual financials are not yet available for this stock.
Revenue and earnings of other Biotechnology stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.